{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:22:06Z","timestamp":1795119726375,"version":"4.10.3"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/7\/1747\/CH\/Adhoc\/RBMCH-2021"],"award-info":[{"award-number":["5\/7\/1747\/CH\/Adhoc\/RBMCH-2021"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2(19)OBS\/2019-NCD-II"],"award-info":[{"award-number":["3\/1\/2(19)OBS\/2019-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030667","name":"Department of Pediatrics, School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cellsig.2024.111299","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:52:47Z","timestamp":1720965167000},"page":"111299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NF\u03baB acetylation"],"prefix":"10.1016","volume":"121","author":[{"given":"Navya","family":"Malladi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devidas","family":"Lahamge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji Sanjay","family":"Somwanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Kumar","family":"Balani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samhita","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Jahangir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0005","doi-asserted-by":"crossref","DOI":"10.2196\/34809","article-title":"The global, regional, and national burden and trends of NAFLD in 204 countries and territories: an analysis from global burden of disease 2019","volume":"8","author":"Chen","year":"2022","journal-title":"JMIR Public Health Surveill."},{"issue":"16","key":"10.1016\/j.cellsig.2024.111299_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0015","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease","volume":"31","author":"Huh","year":"2022","journal-title":"J. Obes. Metab. Syndr."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111299_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/metabo10070283","article-title":"Transcriptional regulation in non-alcoholic fatty liver disease","volume":"10","author":"Steensels","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13148-019-0702-5","article-title":"Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome","volume":"11","author":"Sinton","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cbpa.2003.12.009","article-title":"Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry","volume":"8","author":"N\u00f8rregaard","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111299_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2023","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.cellsig.2024.111299_bb0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14789450.2021.2007766","article-title":"Protein lysine acetylation and its role in different human pathologies: a proteomic approach","volume":"18","author":"Morales-Tarr\u00e9","year":"2021","journal-title":"Expert Rev. Proteomics"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0055","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","article-title":"Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance","volume":"74","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellsig.2024.111299_bb0060","article-title":"The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol. [Internet]"},{"key":"10.1016\/j.cellsig.2024.111299_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8167273","article-title":"Sirtuins link inflammation and metabolism","volume":"2016","author":"Vachharajani","year":"2016","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.cellsig.2024.111299_bb0070","doi-asserted-by":"crossref","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0075","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4239\/wjd.v5.i6.894","article-title":"Sirtuins as novel players in the pathogenesis of diabetes mellitus","volume":"5","author":"Turkmen","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.cellsig.2024.111299_bb0080","series-title":"Sirtuin Biology in Cancer and Metabolic Disease [Internet]","first-page":"3","article-title":"Chapter 1 - Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide","author":"Maiese","year":"2021"},{"issue":"4","key":"10.1016\/j.cellsig.2024.111299_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124710","article-title":"Sirtuin 2 enhances allergic asthmatic inflammation","volume":"4","author":"Lee","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13223-018-0259-4","article-title":"Histone modifications and their role in epigenetics of atopy and allergic diseases","volume":"14","author":"Alaskhar Alhamwe","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111299_bb0095","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/cancers12071714","article-title":"Current and future treatments in the fight against non-alcoholic fatty liver disease","volume":"12","author":"Smeuninx","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0100","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2024.111299_bb0105","article-title":"Vitamin D level and vitamin D receptor genetic variation were involved in the risk of non-alcoholic fatty liver disease: a case-control study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0110","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.25930","article-title":"Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus","volume":"56","author":"Barchetta","year":"2012","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"38","key":"10.1016\/j.cellsig.2024.111299_bb0115","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3748\/wjg.v26.i38.5812","article-title":"Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?","volume":"26","author":"Cao","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2024.111299_bb0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2021.04.019","article-title":"Paricalcitol inhibits oxidative stress-induced cell senescence of the bile duct epithelium dependent on modulating Sirt1 pathway in cholestatic mice","volume":"169","author":"Jia","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.cellsig.2024.111299_bb0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.36472\/msd.v7i7.393","article-title":"The effect of paricalcitol on hepatitis B immunization in hemodialysis patients: the effect of paricalcitol on hepatitis B immunization","volume":"7","author":"Demir","year":"2020","journal-title":"Med. Sci. Discov."},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0135","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41374-019-0310-1","article-title":"Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model","volume":"99","author":"Reiter","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cellsig.2024.111299_bb0140","article-title":"The vitamin D analogue paricalcitol attenuates hepatic ischemia\/reperfusion injury through down-regulation of toll-like receptor 4 signaling in rats","volume":"13","author":"Kim","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2022.102297","article-title":"Oleic acid-induced steatosis model establishment in LMH cells and its effect on lipid metabolism","volume":"102","author":"Song","year":"2023","journal-title":"Poult. Sci."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2024.111299_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.10.126","article-title":"Effect of resveratrol on sirtuins expression and cardiac complications in diabetes","volume":"468","author":"Bagul","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2024.111299_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75301-4","article-title":"Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation","volume":"10","author":"Katare","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cellsig.2024.111299_bb0170","series-title":"Methods of Enzymatic Analysis","first-page":"673","article-title":"Catalase","author":"Aebi","year":"1974"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2024.111299_bb0175","first-page":"88","article-title":"The in vitro antioxidant activity and total phenolic content of four Indian medicinal plants","volume":"1","author":"Zahin","year":"2009","journal-title":"Int J Pharm Pharm Sci"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0180","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1074\/jbc.M805329200","article-title":"Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation","volume":"284","author":"Maity","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0185","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","article-title":"Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity","volume":"87","author":"Krawisz","year":"1984","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.cellsig.2024.111299_bb0190","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.7150\/ijms.27953","article-title":"Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease","volume":"15","author":"Lakhani","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2024.111299_bb0195","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2024.111299_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106766","article-title":"The role of platelets in non-alcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"169","author":"Malladi","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.cellsig.2024.111299_bb0205","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1038\/s41467-021-26657-2","article-title":"Lysine acetylation regulates the interaction between proteins and membranes","volume":"12","author":"Okada","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2024.111299_bb0210","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.celrep.2019.02.035","article-title":"Ets1-mediated acetylation of FoxO1 is critical for gluconeogenesis regulation during feed-fast cycles","volume":"26","author":"Li","year":"2019","journal-title":"Cell Rep."},{"issue":"44","key":"10.1016\/j.cellsig.2024.111299_bb0215","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism*","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12864-020-06837-y","article-title":"Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease","volume":"21","author":"Le-Tian","year":"2020","journal-title":"BMC Genomics"},{"issue":"24","key":"10.1016\/j.cellsig.2024.111299_bb0225","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/MCB.00665-15","article-title":"Lysine acetylation of CREBH regulates fasting-induced hepatic lipid metabolism","volume":"35","author":"Kim","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2024.111299_bb0230","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s13238-015-0204-y","article-title":"Role of transcription factor acetylation in the regulation of metabolic homeostasis","volume":"6","author":"Park","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.cellsig.2024.111299_bb0235","article-title":"Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study","volume":"9","author":"Tomah","year":"2023","journal-title":"Clin. Diabetes Endocrinol. [Internet]"},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0240","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/hepr.13323","article-title":"Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise","volume":"49","author":"Piguet","year":"2019","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"17","author":"Fern\u00e1ndez","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0250","article-title":"Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in Northern India","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellsig.2024.111299_bb0260","article-title":"Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials","volume":"10","author":"Hariri","year":"2019","journal-title":"Int. J. Prev. Med. [Internet]"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11845-017-1635-7","article-title":"Effect of paricalcitol on pancreatic oxidative stress, inflammatory markers, and glycemic status in diabetic rats","volume":"187","author":"Ali","year":"2018","journal-title":"Ir. J. Med. Sci. (1971 -)"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0270","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/ijms24020969","article-title":"Paricalcitol ameliorates acute kidney injury in mice by suppressing oxidative stress and inflammation via Nrf2\/HO-1 signaling","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2024.111299_bb0275","first-page":"149","article-title":"The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection","volume":"8","author":"Duplancic","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.cellsig.2024.111299_bb0280","article-title":"Successful treatment of severe atopic dermatitis with calcitriol and paricalcitol in an 8-year-old girl","volume":"2018","author":"Bothou","year":"2018","journal-title":"Case Rep. Pediatr."},{"key":"10.1016\/j.cellsig.2024.111299_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118404","article-title":"Hypoxia aggravates non-alcoholic fatty liver disease in presence of high fat choline deficient diet: a pilot study","volume":"260","author":"Sarkar","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0290","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/jcm9051294","article-title":"Inhibition of protein-tyrosine phosphatase PTP1B and LMPTP promotes palmitate\/oleate-challenged HepG2 cell survival by reducing lipoapoptosis, improving mitochondrial dynamics and mitigating oxidative and endoplasmic reticulum stress","volume":"9","author":"Bourebaba","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cellsig.2024.111299_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265444","article-title":"Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4\u2014with improving insulin resistance","volume":"17","author":"Peng","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0305","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clnu.2016.09.020","article-title":"Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: randomized, controlled, double-blind trial","volume":"36","author":"Lorvand Amiri","year":"2017","journal-title":"Clin. Nutr. (Edinburgh, Scotland)"},{"key":"10.1016\/j.cellsig.2024.111299_bb0310","article-title":"Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Endocrinol. [Internet]"},{"issue":"9","key":"10.1016\/j.cellsig.2024.111299_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214349","article-title":"Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-\u03b1, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats. Mukhopadhyay P, editor","volume":"14","author":"Ahmed","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0320","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0325","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-5996-5-8","article-title":"The effect of vitamin D on insulin resistance in patients with type 2 diabetes","volume":"5","author":"Talaei","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111299_bb0335","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of dyslipidemia in patients with non-alcoholic fatty liver disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0340","first-page":"1","article-title":"Association of lipid profile and liver parameters with different grades of non-alcoholic fatty liver disease","volume":"5","author":"Baghel","year":"2023","journal-title":"Int. J. Sci. Res. Dent. Med. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111299_bb0345","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/BJ20100791","article-title":"Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation","volume":"433","author":"Kendrick","year":"2011","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111299_bb0350","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/jcp.25711","article-title":"SIRT1-SIRT3 axis regulates cellular response to oxidative stress and etoposide","volume":"232","author":"Carnevale","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111299_bb0355","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.cellsig.2024.111299_bb0360","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","article-title":"Therapeutic effect of sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy","volume":"18","author":"Li","year":"2018","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2024.111299_bb0365","article-title":"Downregulation of sirtuin 3 by palmitic acid increases the oxidative stress, impairment of mitochondrial function, and apoptosis in liver cells","volume":"33","author":"Sharma","year":"2019","journal-title":"J. Biochem. Mol. Toxicol. [Internet]"},{"key":"10.1016\/j.cellsig.2024.111299_bb0370","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12944-021-01461-5","article-title":"Elucidation of SIRT-1\/PGC-1\u03b1-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease","volume":"20","author":"Jiang","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41387-021-00168-x","article-title":"The effect of daily intake of vitamin D-fortified yogurt drink, with and without added calcium, on serum adiponectin and sirtuins 1 and 6 in adult subjects with type 2 diabetes","volume":"11","author":"Nikooyeh","year":"2021","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.cellsig.2024.111299_bb0380","article-title":"The protective effect of 1,25(OH)2D3 on myocardial function is mediated via sirtuin 3-regulated fatty acid metabolism","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0385","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12882-017-0691-6","article-title":"Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials","volume":"18","author":"Xie","year":"2017","journal-title":"BMC Nephrol."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111299_bb0390","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ceb.2008.03.012","article-title":"Transcriptional targets of sirtuins in the coordination of mammalian physiology","volume":"20","author":"Feige","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2024.111299_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046364","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cellsig.2024.111299_bb0400","first-page":"463","article-title":"Effect of NF-\u03baB on the pathogenic course of non-alcoholic fatty liver disease","volume":"42","author":"Wu","year":"2017","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0405","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/CS20090549","article-title":"Role of nuclear factor \u03baB in liver health and disease","volume":"118","author":"Robinson","year":"2010","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0410","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0415","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1084\/jem.20030299","article-title":"IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions","volume":"198","author":"Matsuki","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0420","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0043-118666","article-title":"Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model","volume":"50","author":"Kakino","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0425","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cellsig.2024.111299_bb0430","article-title":"Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA\/p65","volume":"36","author":"C B, KM R, T V, HR O, H R, M F","year":"2008","journal-title":"Nucleic Acids Res. [Internet]"},{"issue":"16","key":"10.1016\/j.cellsig.2024.111299_bb0435","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1101\/gad.1958410","article-title":"Constitutively active NF-\u03baB triggers systemic TNF\u03b1-dependent inflammation and localized TNF\u03b1-independent inflammatory disease","volume":"24","author":"Dong","year":"2010","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.cellsig.2024.111299_bb0440","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","article-title":"Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3","volume":"26","author":"Bagul","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0445","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cells7120235","article-title":"SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM","volume":"7","author":"Bagul","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.cellsig.2024.111299_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110309","article-title":"Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast","volume":"94","author":"Bugga","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2024.111299_bb0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4196\/kjpp.2015.19.5.451","article-title":"Myeloid-specific SIRT1 deletion aggravates hepatic inflammation and steatosis in high-fat diet-fed mice","volume":"19","author":"Kim","year":"2015","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111299_bb0460","first-page":"1638","article-title":"Protective effect of dihydromyricetin revents fatty liver through nuclear factor-\u03baB\/p53\/B-cell lymphoma 2-associated X protein signaling pathways in a rat model","volume":"19","author":"Guo","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2024.111299_bb0465","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2017.06.047","article-title":"Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4\/MyD88\/MAPK\/NF-kB signaling pathways","volume":"490","author":"Kang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111299_bb0470","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2024.111299_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.595371","article-title":"Oxidative stress in non-alcoholic fatty liver disease. An updated mini review","volume":"8","author":"Delli Bovi","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.cellsig.2024.111299_bb0480","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5080843","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.cellsig.2024.111299_bb0485","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"issue":"13","key":"10.1016\/j.cellsig.2024.111299_bb0490","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/ars.2012.4713","article-title":"SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a\/PGC-1\u03b1 complex","volume":"19","author":"Olmos","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cellsig.2024.111299_bb0495","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2015.10.048","article-title":"Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia","volume":"311","author":"Rangarajan","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0500","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12944-019-1132-2","article-title":"FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c","volume":"18","author":"Wang","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0505","doi-asserted-by":"crossref","first-page":"44597","DOI":"10.1038\/srep44597","article-title":"FOXO transcription factors protect against the diet-induced fatty liver disease","volume":"7","author":"Pan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2024.111299_bb0510","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jff.2018.11.053","article-title":"Estradiol ameliorates antioxidant axis SIRT1-FoxO3a-MnSOD\/catalase in the heart of fructose-fed ovariectomized rats","volume":"52","author":"Boskovic","year":"2019","journal-title":"J. Funct. Foods"},{"issue":"12","key":"10.1016\/j.cellsig.2024.111299_bb0515","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/antiox11122478","article-title":"Role of FOXO3a transcription factor in the regulation of liver oxidative injury","volume":"11","author":"Jin","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111299_bb0520","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BJ20140213","article-title":"SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia","volume":"464","author":"Tseng","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2024.111299_bb0525","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2016.12.005","article-title":"Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1\/FOXO3a pathway","volume":"126","author":"Wang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111299_bb0530","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ajpath.2013.08.011","article-title":"Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity","volume":"183","author":"Ni","year":"2013","journal-title":"Am. J. Pathol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824002675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824002675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:36:58Z","timestamp":1778701018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824002675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":106,"alternative-id":["S0898656824002675"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111299","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NF\u03baB acetylation","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111299"}}